Immunosuppressive Agents: all 5,940 studies that test it
Page 56 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic AmyloidosisCompletedNCT00089167Phase 2
- Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00089050Phase 2
- Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00089037Phase 1/2
- Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00086775Phase 2
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00085449Phase 1/2
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesStatus unknownNCT00084695Phase 2
- Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage TherapyCompletedNCT00083902Phase 2
- D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple MyelomaCompletedNCT00083876Phase 3
- Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00083707Phase 2
- Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory LeukemiaCompletedNCT00083694Phase 2
- DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation RelapseCompletedNCT00083681Phase 2
- Anti-Angiogenesis Therapy Using Thalidomide in Multiple MyelomaCompletedNCT00083577Phase 2
- Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and ThalidomideCompletedNCT00083408Phase 2
- Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00083161Phase 2
- Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast CancerCompletedNCT00083031Phase 2
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the ProstateCompletedNCT00083005Phase 2
- High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00082797Phase 2
- RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell LymphomaCompletedNCT00081874Phase 1/2
- An Open Protocol for the Compassionate Use of ThalidomideCompletedNCT00081757Phase 1/2
- S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's LymphomaTerminatedNCT00080847Phase 2
- Daclizumab to Treat HIV-Infected PatientsCompletedNCT00080431Phase 1
- FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaTerminatedNCT00079443Phase 2
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00079261Phase 2
- A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 YearsCompletedNCT00079105Phase 2
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00079092Phase 2
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- Daclizumab and Sirolimus to Treat UveitisCompletedNCT00078689Phase 1
- 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00077558Phase 1
- Safety of RG2077 in Patients With Multiple SclerosisCompletedNCT00076934Phase 1
- Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or NeuroblastomaCompletedNCT00075634Phase 1
- Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS LymphomaCompletedNCT00074191Phase 2
- Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS LymphomaCompletedNCT00074178Phase 2
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast CancerWithdrawnNCT00074139Phase 1
- Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00073879Not applicable
- Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative ColitisCompletedNCT00073047Phase 2
- A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)CompletedNCT00072969Phase 2
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaCompletedNCT00072345Phase 2
- Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00072319Phase 2
- Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to MelanomaCompletedNCT00072163Phase 2
- Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLLCompletedNCT00072007Phase 2
- Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple SclerosisCompletedNCT00071838Phase 2
- Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersCompletedNCT00071227Phase 1
- Daclizumab to Treat Non-Infectious Sight-Threatening UveitisCompletedNCT00070759Phase 2
- Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell LymphomaCompletedNCT00070447Phase 2
- Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast CancerStatus unknownNCT00070278Phase 3
- Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive NeuroblastomaCompletedNCT00070200Phase 1
- Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00070187Phase 2/3
- Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaCompletedNCT00070083Phase 1
- Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00068315Phase 1
- Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's LymphomaTerminatedNCT00068302Phase 1
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00066794Phase 2
- Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell TumorsCompletedNCT00066482Not applicable
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
- Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00063869Phase 2
- ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.CompletedNCT00063830Phase 2
- ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative ColitisCompletedNCT00063414Phase 2
- Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00062140Phase 1
- Irinotecan and Thalidomide in Treating Patients With Advanced Solid TumorsCompletedNCT00062127Phase 1
- Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic MelanomaCompletedNCT00062036Phase 1/2
- Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung CancerCompletedNCT00061919Phase 3
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Epirubicin and Thalidomide in Treating Patients With Liver CancerCompletedNCT00058487Phase 2
- Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaCompletedNCT00058227Phase 1
- A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple MyelomaCompletedNCT00057564Phase 3
- Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell TransplantationCompletedNCT00057005Phase 1
- Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00056095Phase 2
- Combination Chemotherapy in Treating Women With Stage I Breast CancerCompletedNCT00055679Phase 3
- Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative DisorderCompletedNCT00054340Phase 1/2
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple MyelomaCompletedNCT00054158Phase 2
- Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host DiseaseCompletedNCT00053976Phase 3
- Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected PeopleCompletedNCT00053430Phase 2
- Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00053300Phase 2
- Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDSCompletedNCT00053287Phase 2
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell LymphomaCompletedNCT00053092Phase 2
- Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedNCT00053027Phase 2
- Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNCT00053001Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaCompletedNCT00052936Phase 3
- Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00052416Phase 1
- A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneTerminatedNCT00052039Phase 3
- Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular CarcinomaTerminatedNCT00051545Phase 3
- Seocalcitol Versus Placebo in Advanced Hepatocellular CarcinomaTerminatedNCT00051532Not applicable
- A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic SyndromesCompletedNCT00050843Phase 3
- Sirolimus Therapy for Idiopathic and Lupus Membranous NephropathyCompletedNCT00050713Phase 2
- To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis VulgarisCompletedNCT00050661Phase 1/2
- To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis VulgarisCompletedNCT00050648Phase 1/2
- Daclizumab to Treat Chronic Immune ThrombocytopeniaCompletedNCT00049725Phase 2
- Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaCompletedNCT00049413Phase 2
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00049374Phase 2
- Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain MetastasesCompletedNCT00049361Phase 2
- Thalidomide and Docetaxel in Treating Patients With Advanced CancerCompletedNCT00049296Phase 1
- Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast CancerCompletedNCT00049114Phase 2
- Fludarabine in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00049075Phase 2
- Treatment of Resistant Langerhans Cell Histiocytosis With ENBRELCompletedNCT00048373Phase 2
- Alicaforsen (ISIS 2302) in Patients With Active Crohn's DiseaseCompletedNCT00048295Phase 3
- A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant PatientsCompletedNCT00048152Phase 3
- Alicaforsen (ISIS 2302) in Patients With Active Crohn's DiseaseCompletedNCT00048113Phase 3
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00047294Phase 2
- Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant GliomaCompletedNCT00047281Phase 2